FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200604345> ?p ?o ?g. }

• W4200604345 endingPage "810" @default.
• W4200604345 startingPage "798" @default.
• W4200604345 abstract "The present investigation comprised two independent observational arms to evaluate the influence of pre-existing flavivirus humoral immunity and the age-impact on 17DD-YF vaccination immunity. Flavivirus (YFV; DENV; ZIKV) serology and YF-specific cellular immunity was evaluated in 288 children/9Mths-4Yrs and 288 adults/18-49Yrs residents of areas without YFV circulation. Data demonstrated that flavivirus seropositivity at baseline was higher in Adults as compared to Children (26%;87%;67% vs 6%;13%;15%, respectively). The heterologous flavivirus seropositivity (DENV; ZIKV) did not impact the YF-specific cellular immune response at baseline. However, higher levels of NCD4, EMCD8, IFN-MCD8, NCD19 and nCMCD19 were observed in subjects with pre-existing YFV seropositivity. Primary vaccination of YFV-seronegative volunteers led to higher levels of YF-neutralizing antibodies in Adults as compared to Younger Children (9Mths-2Yrs). Although similar seropositivity rates observed amongst Children and Adults at D30-45, lower rates were observed in Younger Children (9Mths-2Yrs) at D365 (94%;95%;100% vs 87%;96%;99%, respectively). A progressive decline in antibody levels were reported at D365, being more expressive in Children as compared to Adults. All age-subgroups exhibited at D30-45 increased levels of eEfCD4, EMCD4, IFN-MCD8 and nCMCD19 together with a decrease of eEfCD8 and CMCD8. While an increase of EMCD8 were observed in all subgroups at D30-45, a declined duration at D365 was reported only in Younger Children (9Mths-2Yrs). Biomarker signatures further support that only Younger Children (9Mths-2Yrs) presented a progressive decline of EMCD8 at D365. Together, these findings demonstrated that regardless the similarities observed in YF-neutralizing antibodies, the age impacts the duration of cellular immune response to primary 17DD-YF vaccination." @default.
• W4200604345 created "2021-12-31" @default.
• W4200604345 creator A5000181209 @default.
• W4200604345 creator A5004322829 @default.
• W4200604345 creator A5013915925 @default.
• W4200604345 creator A5014066762 @default.
• W4200604345 creator A5017523406 @default.
• W4200604345 creator A5018625719 @default.
• W4200604345 creator A5020233707 @default.
• W4200604345 creator A5022976564 @default.
• W4200604345 creator A5035096953 @default.
• W4200604345 creator A5045098466 @default.
• W4200604345 creator A5045226298 @default.
• W4200604345 creator A5047418145 @default.
• W4200604345 creator A5051101558 @default.
• W4200604345 creator A5055017119 @default.
• W4200604345 creator A5059003875 @default.
• W4200604345 creator A5061040155 @default.
• W4200604345 creator A5066477700 @default.
• W4200604345 creator A5069840023 @default.
• W4200604345 creator A5070560214 @default.
• W4200604345 creator A5073659588 @default.
• W4200604345 creator A5085605821 @default.
• W4200604345 creator A5086711499 @default.
• W4200604345 creator A5090051139 @default.
• W4200604345 creator A5090449809 @default.
• W4200604345 creator A5090673357 @default.
• W4200604345 date "2022-01-01" @default.
• W4200604345 modified "2023-10-16" @default.
• W4200604345 title "Exploratory study of humoral and cellular immunity to 17DD Yellow Fever vaccination in children and adults residents of areas without circulation of Yellow Fever Virus" @default.
• W4200604345 cites W1784744653 @default.
• W4200604345 cites W1942616017 @default.
• W4200604345 cites W1975444243 @default.
• W4200604345 cites W1999787262 @default.
• W4200604345 cites W2065076563 @default.
• W4200604345 cites W2111553271 @default.
• W4200604345 cites W2113750576 @default.
• W4200604345 cites W2113847305 @default.
• W4200604345 cites W2144902263 @default.
• W4200604345 cites W2155083074 @default.
• W4200604345 cites W2168028856 @default.
• W4200604345 cites W2171545494 @default.
• W4200604345 cites W2271750230 @default.
• W4200604345 cites W2277984065 @default.
• W4200604345 cites W2469258508 @default.
• W4200604345 cites W2525083533 @default.
• W4200604345 cites W2530451707 @default.
• W4200604345 cites W2741680107 @default.
• W4200604345 cites W2746243082 @default.
• W4200604345 cites W2777057590 @default.
• W4200604345 cites W2795840126 @default.
• W4200604345 cites W2806145862 @default.
• W4200604345 cites W2888463146 @default.
• W4200604345 cites W2910475883 @default.
• W4200604345 cites W2954164294 @default.
• W4200604345 cites W2971095613 @default.
• W4200604345 cites W2974770100 @default.
• W4200604345 cites W2977705160 @default.
• W4200604345 cites W3005653862 @default.
• W4200604345 cites W3007431900 @default.
• W4200604345 cites W3041424018 @default.
• W4200604345 cites W4240905451 @default.
• W4200604345 cites W4247556392 @default.
• W4200604345 doi "https://doi.org/10.1016/j.vaccine.2021.12.029" @default.
• W4200604345 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34969545" @default.
• W4200604345 hasPublicationYear "2022" @default.
• W4200604345 type Work @default.
• W4200604345 citedByCount "2" @default.
• W4200604345 countsByYear W42006043452022 @default.
• W4200604345 countsByYear W42006043452023 @default.
• W4200604345 crossrefType "journal-article" @default.
• W4200604345 hasAuthorship W4200604345A5000181209 @default.
• W4200604345 hasAuthorship W4200604345A5004322829 @default.
• W4200604345 hasAuthorship W4200604345A5013915925 @default.
• W4200604345 hasAuthorship W4200604345A5014066762 @default.
• W4200604345 hasAuthorship W4200604345A5017523406 @default.
• W4200604345 hasAuthorship W4200604345A5018625719 @default.
• W4200604345 hasAuthorship W4200604345A5020233707 @default.
• W4200604345 hasAuthorship W4200604345A5022976564 @default.
• W4200604345 hasAuthorship W4200604345A5035096953 @default.
• W4200604345 hasAuthorship W4200604345A5045098466 @default.
• W4200604345 hasAuthorship W4200604345A5045226298 @default.
• W4200604345 hasAuthorship W4200604345A5047418145 @default.
• W4200604345 hasAuthorship W4200604345A5051101558 @default.
• W4200604345 hasAuthorship W4200604345A5055017119 @default.
• W4200604345 hasAuthorship W4200604345A5059003875 @default.
• W4200604345 hasAuthorship W4200604345A5061040155 @default.
• W4200604345 hasAuthorship W4200604345A5066477700 @default.
• W4200604345 hasAuthorship W4200604345A5069840023 @default.
• W4200604345 hasAuthorship W4200604345A5070560214 @default.
• W4200604345 hasAuthorship W4200604345A5073659588 @default.
• W4200604345 hasAuthorship W4200604345A5085605821 @default.
• W4200604345 hasAuthorship W4200604345A5086711499 @default.
• W4200604345 hasAuthorship W4200604345A5090051139 @default.
• W4200604345 hasAuthorship W4200604345A5090449809 @default.
• W4200604345 hasAuthorship W4200604345A5090673357 @default.
• W4200604345 hasConcept C159047783 @default.
• W4200604345 hasConcept C159654299 @default.

• next